Document Detail

Renal medullary carcinoma: prolonged remission with chemotherapy, immunohistochemical characterisation and evidence of bcr/abl rearrangement.
MedLine Citation:
PMID:  10573578     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Renal medullary carcinoma (RMC), an extremely rare tumour of the kidney, carries a dismal prognosis, with no reports to date of significant response to chemotherapy or radiotherapy. A case of this tumour in a male child, who showed a dramatic response to chemotherapy, is described. PROCEDURE: A detailed histological evaluation of the tumour and cytogenetic analysis using fluorescent in situ hybridisation (FISH) was carried out. The child was treated with multiagent chemotherapy, followed by abdominal radiotherapy. RESULTS: A detailed histopathological and immunohistochemical portrait of this tumour is described, and FISH studies confirmed the presence of a bcr/abl rearrangement. The child obtained complete radiological remission following chemotherapy, although he later relapsed and died of progressive disease despite further attempts at treatment with chemotherapy. CONCLUSIONS: Although there are no previous reports of response of this tumour to chemotherapy, this case illustrates that treatment of this disease is justified. The responses of other cases to similar drug regimens would be of interest to confirm whether the encouraging response described for this case could be reproduced. Cytogenetic analysis of other cases of RMC may clarify whether the abnormalities seen in this case are typical.
J Stahlschmidt; C Cullinane; P Roberts; S V Picton
Related Documents :
18452128 - Loss of heterozygosity at 9q32-33 (dbc1 locus) in primary non-invasive papillary urothe...
12943628 - Merkel cell carcinoma: a clinicopathological study of 34 patients.
19787248 - Immunophenotyping of diffuse large b-cell lymphoma (dlbcl) defines multiple sub-groups ...
1879068 - Is laterality important in neck node metastases in head and neck cancer?
18385198 - Temsirolimus safety profile and management of toxic effects in patients with advanced r...
9367708 - S-phase fraction, p53, and her-2/neu status as predictors of nodal metastasis in early ...
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Medical and pediatric oncology     Volume:  33     ISSN:  0098-1532     ISO Abbreviation:  Med. Pediatr. Oncol.     Publication Date:  1999 Dec 
Date Detail:
Created Date:  2000-01-11     Completed Date:  2000-01-11     Revised Date:  2006-04-24    
Medline Journal Info:
Nlm Unique ID:  7506654     Medline TA:  Med Pediatr Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  551-7     Citation Subset:  IM    
Copyright Information:
Copyright 1999 Wiley-Liss, Inc.
Department of Histopathology, St. James's University Hospital, Leeds, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Medullary / drug therapy*,  genetics,  metabolism,  pathology,  radiography
Fatal Outcome
Fusion Proteins, bcr-abl / genetics*
In Situ Hybridization, Fluorescence
Kidney Neoplasms / drug therapy*,  genetics,  metabolism,  pathology,  radiography
Remission Induction
Tomography, X-Ray Computed
Translocation, Genetic / genetics
Reg. No./Substance:
0/Fusion Proteins, bcr-abl

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Motor performance of children during treatment for acute lymphoblastic leukemia.
Next Document:  Tolerance of half-body irradiation as systemic therapy for patients with locally advanced breast can...